Positron Corporation (POSC)
OTCMKTS · Delayed Price · Currency is USD
2.499
+0.059 (2.40%)
At close: Feb 27, 2026
Positron Revenue
Positron had revenue of $111.00K in the quarter ending September 30, 2025, a decrease of -66.16%. This brings the company's revenue in the last twelve months to $486.45K, down -63.40% year-over-year. In the year 2024, Positron had annual revenue of $587.50K, down -20.03%.
Revenue (ttm)
486.45K
Revenue Growth
-63.40%
P/S Ratio
168.72
Revenue / Employee
48.65K
Employees
10
Market Cap
82.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 587.50K | -147.17K | -20.03% |
| Dec 31, 2023 | 734.67K | -731.33K | -49.89% |
| Dec 31, 2014 | 1.47M | -164.00K | -10.06% |
| Dec 31, 2013 | 1.63M | -1.17M | -41.81% |
| Dec 31, 2012 | 2.80M | -3.86M | -57.96% |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.11M |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |
| REMSleep Holdings | 6.73K |